2005
DOI: 10.1038/sj.gt.3302618
|View full text |Cite
|
Sign up to set email alerts
|

Use of adenoviral vectors as veterinary vaccines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
34
0

Year Published

2005
2005
2019
2019

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 69 publications
(34 citation statements)
references
References 89 publications
(101 reference statements)
0
34
0
Order By: Relevance
“…27,28 In this study, AdEasy-1 system has been selected for generation of recombinant adenoviruses encoding hNET gene. Compared with traditional adenoviral vectors, the AdEasy-1 system incorporates several unusual features.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…27,28 In this study, AdEasy-1 system has been selected for generation of recombinant adenoviruses encoding hNET gene. Compared with traditional adenoviral vectors, the AdEasy-1 system incorporates several unusual features.…”
Section: Discussionmentioning
confidence: 99%
“…Second, the recombination step is performed in Escherichia coli rather than in mammalian cells, taking advantage of the high efficiency of homologous recombination in bacteria. 28 Furthermore, there is no need to carry out laborious plaque purification rounds, which reduce the needed time to generate a recombinant adenovirus, to several weeks.…”
Section: Discussionmentioning
confidence: 99%
“…The genome of non integrating viral vectors, such as adenoviruses, will get lost after several cell divisions, but these viruses have been shown to be useful in gene therapy approaches in cancer research (Gallo et al, 2005), or new developments of vaccines in veterinary medicine (Ferreira et al, 2005). …”
Section: Vector Designmentioning
confidence: 99%
“…Gene therapy is increasingly viewed as a novel form of drug therapy and a source of new therapeutic products for pharmaceutical companies [1,2]. Adenoviral vectors are currently the most utilized viral vectors in gene therapy industry [3].…”
Section: Introductionmentioning
confidence: 99%